All Stories

  1. Facile Attachment of Halides and Pseudohalides to Dodecaborate(2-) via Pd-catalyzed Cross-Coupling
  2. An affordable gradient mixer for chromatography with aqueous and organic solvents
  3. New approaches to the functionalization of the 1-carba-closo-decaborate anion
  4. Toxicity and phototoxicity in human ARPE-19 retinal pigment epithelium cells of dyes commonly used in retinal surgery
  5. The chaotropic effect as an orthogonal assembly motif for multi-responsive dodecaborate-cucurbituril supramolecular networks
  6. Polyhalogenated Decaborate and 1‐Ammoniododecaborate Ions: An Improved Synthesis with Elemental Halogens, and Physicochemical and Chemical Properties
  7. From boron clusters to gold clusters: new label-free colorimetric sensors
  8. Dodecaborate-Functionalized Anchor Dyes for Cyclodextrin-Based Indicator Displacement Applications
  9. High-affinity host–guest chemistry of large-ring cyclodextrins
  10. Assessment of the eye irritation potential of chemicals: A comparison study between two test methods based on human 3D hemi-cornea models
  11. Water Structure Recovery in Chaotropic Anion Recognition: High-Affinity Binding of Dodecaborate Clusters to γ-Cyclodextrin
  12. Opening of an icosahedral boron framework: A combined infrared spectroscopic and computational study
  13. Development of an in vitro ocular test system for the prediction of all three GHS categories
  14. Halogenated Dodecaborate Clusters as Agents to Trigger Release of Liposomal Contents
  15. Boron clusters in medicinal chemistry: perspectives and problems
  16. Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy
  17. Case numbers for a randomized clinical trial of boron neutron capture therapy for Glioblastoma multiforme
  18. Interaction of organic compounds and boron clusters with new silica matrices containing the phosphatidylcholine headgroup
  19. Synthesis and photochemical properties of phthalocyanine zinc(II) complexes containing o-carborane units
  20. [FeFe]-Hydrogenase models assembled into vesicular structures
  21. Brilliant Blue G as protective agent against trypan blue toxicity in human retinal pigment epithelial cells in vitro
  22. On the gas-phase dimerization of negatively charged closo-dodecaborates: a theoretical study
  23. Dyes for Eyes™: Hydrodynamics, Biocompatibility and Efficacy of ‘Heavy' (Dual) Dyes for Chromovitrectomy
  24. From an Icosahedron to a Plane: Flattening Dodecaiodo‐dodecaborate by Successive Stripping of Iodine
  25. Interaction of dodecaborate cluster compounds on hydrophilic column materials in water
  26. Structure and Dynamics of Dodecaborate Clusters in Water
  27. Cesium and Tetrabutylammonium Salt of the Ethynyl-closo-dodecaborate Dianion
  28. Boron Determination in Liver Tissue by Combining Quantitative Neutron Capture Radiography (QNCR) and Histological Analysis for BNCT Treatment Planning at the TRIGA Mainz
  29. Comparative Toxicology of Trypan Blue, Brilliant Blue G, and Their Combination Together with Polyethylene Glycol on Human Pigment Epithelial Cells
  30. Charge Transfer via the Dative N−B Bond and Dihydrogen Contacts. Experimental and Theoretical Electron Density Studies of Four Deltahedral Boranes
  31. Collision-induced gas-phase reactions of perhalogenated closo-dodecaborate clusters – a comparative study
  32. Real-Space Indicators for Chemical Bonding. Experimental and Theoretical Electron Density Studies of Four Deltahedral Boranes
  33. Drug-Membrane Interaction on Immobilized Liposome Chromatography Compared to Immobilized Artificial Membrane (IAM), Liposome/Water, and Octan-1-ol/Water Systems
  34. Synthesis and structure of novel closo-dodecaborate-based glycerols
  35. Interaction of N,N,N-trialkylammonioundecahydro-closo-dodecaborates with dipalmitoyl phosphatidylcholine liposomes
  36. Pyridinium Lipids with the Dodecaborate Cluster as Polar Headgroup: Synthesis, Characterization of the Physical−Chemical Behavior, and Toxicity in Cell Culture
  37. Dodecaborate cluster lipids with variable headgroups for boron neutron capture therapy: Synthesis, physical–chemical properties and toxicity
  38. N-arylammonio- and N-pyridinium-substituted derivatives of dodecahydro-closo-dodecaborate(2-)
  39. Interaction of Na2B12H11SH with dimyristoyl phosphatidylcholine liposomes
  40. SEARCH FOR LOW-ENERGY CONFORMATIONS OF A NEUROTOXIC PROTEIN BY MEANS OF PREDICTIVE RULES, TESTS FOR HARD-SPHERE OVERLAPS, AND ENERGY MINIMIZATION*
  41. A Model Of The Three-Dimensional Structure Of Snake Venom Neurotoxins Based On Chemical Evidence
  42. Toxicity of N,N,N-trialkylammoniododecaborates as new anions of ionic liquids in cellular, liposomal and enzymatic test systems
  43. N ‐Alkylation of Ammonioundecahydro‐ closo ‐dodecaborate(1–) for the Preparation of Anions for Ionic Liquids
  44. Synthesis and characterization of azanonaborane-containing purine derivatives for boron neutron capture therapy
  45. Synthesis, characterization, and spectrophotometric studies of novel fluorescent arachno decaborane and nonaborane clusters containing aza-distyrylbenzene derivatives
  46. Trialkylammoniododecaborates: Anions for Ionic Liquids with Potassium, Lithium and Protons as Cations
  47. Synthesis, Liposomal Preparation, and in Vitro Toxicity of Two Novel Dodecaborate Cluster Lipids for Boron Neutron Capture Therapy
  48. Synthesis of dodecaborate-conjugated cholesterols for efficient boron delivery in neutron capture therapy
  49. The Anionic Boron Cluster (B12H11SH)2− as a Means To Trigger Release of Liposome Contents
  50. Preparation of Carboranyl and Dodecaborate Derivatives of Coumarin
  51. Azanonaboranes Containing Imidazole Derivatives for Boron Neutron Capture Therapy: Synthesis, Characterization, and In Vitro Toxicity Evaluation
  52. Structure and spectral characteristics of fervenulin and 2-methylfervenulin-3-one 4-N-oxides: Features of the transformations of fervenulin-3-one and its 4-N-oxide with C-nucleophiles
  53. Boron-Containing Chlorins and Tetraazaporphyrins: Synthesis and Cell Uptake of Boronated Pyropheophorbide A Derivatives
  54. The first synthesis of azanonaborane-containing sugars, possible boron carriers for neutron capture therapy
  55. Polypyrrole materials doped with weakly coordinating anions: influence of substituents and the fate of the doping anion during the overoxidation process
  56. Reactions of 3-Alkylsulfonyl Derivatives of 1,2,4-Triazine and Pyrimido[4,5-e][1,2,4]-triazine with Sodium Mercaptododecaborate: Simple Pathways to Boron-Containing as-Triazines and Thioesters of Sulfinic Acid
  57. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates
  58. B12H11-containing guanidinium derivatives by reaction of carbodiimides with H3N–B12H11(1−). A new method for connecting boron clusters to organic compounds
  59. Fragmentation of B12H11S-R(2−) in electrospray mass spectrometry
  60. Interaction of Na2B12H11SH with liposomes: Influence on zeta potential and particle size
  61. Synthesis of a (B12H11S)2− containing glucuronoside as potential prodrug for BNCT
  62. The first synthesis of boron-containing stable σ-adducts of 5-nitropyrimidine
  63. Unusual reactions of 4,6-dichloro-5-nitropyrimidine with C-nucleophiles
  64. Synthesis of boron-containing heterocyclic compounds
  65. Non-covalent assemblies of negatively charged boronated porphyrins with different cationic moieties
  66. Conjugation of thecloso-Borane Mercaptoundecahydrododecaborate (BSH) to a Tumour Selective Peptide
  67. Cyanuric and Thiocyanuric Acid Esters: New Carriers of Boron-Containing Molecular Fragments
  68. New possibilities of 1,2,4-triazines functionalization: first examples of synthesis and structure of boron-containing 1,2,4-triazines
  69. Cell type selective accumulation of mercaptoundecahydro- closo -dodecaborate (BSH) in glioblastoma multiforme
  70. Cyanuric and thiocyanuric esters as carriers of boron-containing fragments and their fragmentation in mass spectrometry
  71. The chemistry of the azanonaborane cluster RNH2B8H11NHR
  72. Synthesis of triazole- and pyridine-bridged porphyrin–chlorin and porphyrin dimers
  73. New way of the reaction of 1-amino-6,7-difluoro-4-oxoquinolyl-3-ethylcarboxylate with acetoacetone
  74. Synthesis of bipyridine-linked dimers of azanonaborane: electronic absorption and molecular-orbital calculations
  75. Unexpected reactivity of 3-ethylsulfonyl-1,2,4-triazines with B12H11SH⌉2–: first examples of the synthesis of boron-centered as-triazines and thioesters of ethyl sulfinic acid
  76. Synthesis of (Aminoalkylamine)-N-aminoalkyl)azanonaborane(11) Derivatives for Boron Neutron Capture Therapy
  77. Azanonaborane-pyridine derivatives [(R′C5H4N)B8H11NHR″]: synthesis, structure and some molecular-orbital calculations
  78. Azanonaboranes [(RNH2)B8H11NHR] as possible new compounds for use in boron neutron capture therapy
  79. Synthesis and optical properties of novel covalent and non-covalent porphyrin dimers
  80. Synthesis and characterisation of the halogenated azanonaboranes [(iPrNH2)B8H10XNHiPr] (X=Cl, Br, I) and their unexpected hydrolysis to hypho-[B5H10(μ-NHiPr)]
  81. Simple Method for Reduction of Autofluorescence in Fluorescence Microscopy
  82. Polyhedral boron derivatives of porphyrins and phthalocyanines
  83. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma
  84. Stable σ-adducts of 5-azauracil with C-nucleophiles
  85. BNCT Beyond Glioma Treatment
  86. Synthesis of N-substituted derivatives of the hypho-(amine)(amino)B8H11 system
  87. Spectromicroscopy of boron in human glioblastomas following administration ofNa2<...
  88. The formation of boron-carbon bonds to closo-decaborate(2−) and closo-dodecaborate(2−)
  89. Synthesis of alkoxy derivatives of dodecahydro-closo-dodecaborate anion [B12H12]2−
  90. Acylation of [B12H12]2− dianion by carboxylic acid halides
  91. Interaction of mercaptoundecahydrododecaborate (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy
  92. The Compound Factor of the 10 B(n,α) 7 Li Reaction from Borocaptate Sodium and the Relative Biological Effectiveness of Recoil Protons for Induction of Brain Damage in Boron Neutron Capture Therapy
  93. Bor-Neutroneneinfangtherapie von Tumoren
  94. Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture
  95. N ‐Alkylation of Ammine—Undecahydro‐ Closo ‐dodecaborate(1−)
  96. Comparison of Inductively Coupled Plasma Atomic Emission Spectrometry and Inductively Coupled Plasma Mass Spectrometry With Quantitative Neutron Capture Radiography for the Determination of Boron in Biological Samples From Cancer Therapy
  97. Additions and corrections
  98. Reversed-phase separation of ionic organoborate clusters by high-performance liquid chromatography
  99. Clinical phase-I study of NA2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)
  100. Present status and perspectives of boron neutron capture therapy
  101. Synthesis of S-alkyl and S-acyl derivatives of mercaptoundecahydrododecaborate, a possible boron carrier for neutron capture therapy
  102. Biodistribution and toxicity of 2,4-divinyl-nido-o-carboranyldeuteroporphyrin IX in mice
  103. Synthesis and Biological Behavior of a Boronated Analogue of the Antiestrogen U 23,469-M
  104. Boron-containing thiouracil derivatives for neutron-capture therapy of melanoma
  105. The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity
  106. Immunoreactivity of boronated antibodies
  107. New developments in neutron capture therapy
  108. Preparation of carboranyl porphyrins for boron neutron capture therapy
  109. Synthesis of nido-carborate containing thioureas
  110. Third International Symposium on Neutron Capture Therapy, Bremen, 31 May to 3 June, 1988
  111. ACCUMULATION OF PORPHYRINS IN CELLS: INFLUENCE OF HYDROPHOBICITY AGGREGATION AND PROTEIN BINDING
  112. The Monte Carlo Simulation of the Biological Effect of the 10 B(n,α) 7 Li Reaction in Cells and Tissue and Its Implication for Boron Neutron Capture Therapy
  113. Boron uptake in melanoma, cerebrum and blood from Na2B12H11SH and Na4B24H22S2 administered to mice
  114. Microanalytical techniques for boron analysis using the 1 0 B(n ,α)7 Li reaction
  115. The Relative Biological Effectiveness in V79 Chinese Hamster Cells of the Neutron Capture Reactions in Boron and Nitrogen
  116. Boron-loaded macromolecules in experimental physiology: tracing by neutron capture radiography
  117. Temporal, intra- and interspecific variation of proteolytic enzymes in carabid-beetles
  118. Determination of sub-PPM amounts of boron in solutions by means of solid state track detectors
  119. Gas chromatographic adsorption effect arising from boron trihalides
  120. Characterization of silica bonded stationary phases
  121. B-Decachloro-o-carborane Derivatives Suitable for the Preparation of Boron-Labeled Biological Macromolecules
  122. Determination of ligand contents of octadecyl-modified silicas
  123. Quantitative ether cleavage of ligands in hydrophobic agaroses —precise determination of the degree of substitution
  124. Biospecific sample preparation and its application in isoelectric focusing
  125. Rapid zymogen activation and isolation of serine proteases from an individual mouse pancreas by affinity chromatography
  126. [28] Characterization of immobilized enzymes by chemical methods
  127. [36] Conformational transitions in immobilized proteases
  128. Immobilized carboxypeptidase A as a probe for studying the thermally induced unfolding of bovine pancreatic ribonuclease
  129. Active site titration of immobilized chymotrypsin with a fluorogenic reagent
  130. The preparation and primary structure of S-peptides from different pancreatic ribonucleases
  131. Fluorescence Investigation of Immobilized Enzymes
  132. The Denaturation by Urea and Guanidinium Chloride of Trypsin and N-Acetylated-Trypsin Derivatives Bound to Sephadex and Agarose
  133. Cooperative transitions between active α- and β-trypsin conformations
  134. Molecular properties of immobilized proteins
  135. Competitive Inhibition of Sephadex-Bound Chymotrypsin and Trypsin
  136. Changes in conformation of insolubilized trypsin and chymotrypsin, followed by fluorescence
  137. Insolubilized trypsin with activity in 8 M urea
  138. Some Properties of a Bacterial Proteinase Chemically Fixed to Agarose